Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
27.72
+0.56 (+2.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Moderna's Q4 Loss Wider Than Expected
February 14, 2025
The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 vaccine sales.
Via
The Motley Fool
Exposures
COVID-19
Which S&P500 stocks are moving before the opening bell on Friday?
February 14, 2025
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.
Via
Chartmill
Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 14, 2025
Via
Benzinga
Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides
February 14, 2025
Moderna reported a Q4 EPS loss of $2.91, missing estimates, with revenue down 66% YoY to $966 million. The company reaffirmed 2025 guidance and cost-cutting plans.
Via
Benzinga
Exposures
COVID-19
Moderna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations Significantly
February 14, 2025
Biotechnology company Moderna (NASDAQ:MRNA) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other hand, the company’s full-year revenue...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Will Moderna's Retained 2025 Outlook Bolster Its Depressed Shares?
February 14, 2025
The company came up with a mixed fourth-quarter report, but kept its outlook for 2025.
Via
Investor's Business Daily
What the Options Market Tells Us About Moderna
February 11, 2025
Via
Benzinga
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
February 14, 2025
Via
ACCESS Newswire
Dow Jumps Over 300 Points Following Recent Inflation Data; Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
February 14, 2025
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Palo Alto Networks, Moderna And 3 Stocks To Watch Heading Into Friday
February 14, 2025
Via
Benzinga
US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic'
February 14, 2025
U.S. stock futures traded close to the flatline on Friday after Tuesday's rally. Futures of all four benchmark indices were slightly lower.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
February 11, 2025
Via
Benzinga
Earnings Scheduled For February 14, 2025
February 14, 2025
Via
Benzinga
Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 14, 2025
Via
Benzinga
Moderna Q4 Earnings Preview: COVID-19 Vaccine Sales, Bird Flu Vaccine Candidates On Watch
February 13, 2025
Moderna is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at what to expect in the report:
Via
Benzinga
Exposures
COVID-19
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
February 13, 2025
The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Benzinga
Topics
Government
Exposures
Political
Moderna (MRNA) Q4 Earnings Report Preview: What To Look For
February 13, 2025
Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market open. Here’s what to expect.
Via
StockStory
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
February 12, 2025
The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
February 11, 2025
Via
Benzinga
Walmart To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Tuesday
February 11, 2025
Via
Benzinga
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch
February 10, 2025
A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye."
Via
Benzinga
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst
February 10, 2025
U.S. stock futures rose on Monday following Friday's sharp fall as investors digest tariff updates and earnings reports.
Via
Benzinga
Topics
World Trade
Exposures
Tariff
2 Biotech Stocks to Buy Hand Over Fist in February
February 09, 2025
Via
The Motley Fool
Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?
February 09, 2025
Skyworks Solutions, Estee Lauder, Venture Global, Neurocrine Biosciences, Moderna, Illumina, IDEX Corporation, PTC Inc, PayPal Holdings, Skechers U.S.A. and Avantor were worst performers, fell up to...
Via
Benzinga
3 Beaten-Down Stocks That Aren't Worth Buying on the Dip
February 08, 2025
Via
The Motley Fool
10 Worst Performing Large-Caps Last 12 Months
February 06, 2025
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via
Talk Markets
Topics
Stocks / Equities
3 Top AI-Powered Biotech Stocks to Buy in February
February 06, 2025
Via
The Motley Fool
Uncover the latest developments among S&P500 stocks in today's session.
February 04, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.
February 04, 2025
RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines in favor of his nomination.
Via
Investor's Business Daily
Robert F. Kennedy's Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Drop
February 04, 2025
The U.S. Senate Finance Committee on Tuesday voted 14 to 13 in favor of advancing the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.